CRISPR Assays for Disease Diagnosis: Progress to and Barriers Remaining for Clinical Applications

Numerous groups have employed the special properties of CRISPR/Cas systems to develop platforms that have broad potential applications for sensitive and specific detection of nucleic acid (NA) targets. However, few of these approaches have progressed to commercial or clinical applications. This revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zhen, Lyon, Christopher J., Wang, Jin, Lu, Shuihua, Hu, Tony Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369298/
https://www.ncbi.nlm.nih.gov/pubmed/37162202
http://dx.doi.org/10.1002/advs.202301697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369298/
https://www.ncbi.nlm.nih.gov/pubmed/37162202
http://dx.doi.org/10.1002/advs.202301697

Ejemplares similares